期刊文献+

胃癌组织Axin蛋白的表达与侵袭转移的相关性 被引量:4

Expression of Axin protein correlates with genesis and metastasis of gastric carcinoma
下载PDF
导出
摘要 目的:探讨胃癌组织Axin蛋白的表达与侵袭转移的相关性.方法:胃癌患者46例,均行胃癌根治切除手术.采集胃癌癌组织及远癌正常胃组织标本, 制备石蜡切片,采用免疫组化(SABC)法检测 Axin蛋白的表达,研究其表达和分布特点与临床病理间的关系.结果:正常胃组织Axin蛋白在基底部细胞表达强,表面成熟细胞中表达弱:胃癌组织、远癌正常胃组织中均有Axin蛋白表达,其阳性表达率分别为62.0%和91.3%,差异有统计学意义(P<0.01);Axin蛋白的表达与胃癌临床病理分期(TNM I,ⅡvsⅢ,Ⅳ:78.6% vs 56.3%, P=0.035)、有无淋巴转移有关(无 vs 有:85.7% vs 53.1%,P=0.034),与胃癌患者性别、年龄、肿瘤大小、生物学特征和是否侵及浆膜无关(P>0.05).结论:Axin蛋白表达减弱与胃癌的发生以及肿瘤的临床进展和淋巴转移相关. AIM: To investigate the relationship between Axin protein expression and genesis and metastasis of gastric carcinoma. METHODS: A total of carcinoma underwent included in this study 46 patients with gastric surgical resection were The expression of Axin protein was detected by immunohistochemical techniques (SABC) in paraffin-embedded samples prepared from gastric carcinoma tissues and normal stomach tissues far from the tumor. In addition, the positive rate of Axin expression was calculated and its correlation with the pathological characteristics of gastric carcinoma was analyzed. RESULTS: In normal stomach tissues, Axin protein expression was strongly positive and intensified in basal cells. Axin was also expressed in tissues from gastric carcinoma and normal stomach mucosa far from the tumor with a positive rate of 62.0% and 91.3%, respectively. There was a significant difference between them (P 〈 0.01). Axin protein expression was significantly correlated with clinical TNM classification (TNM Ⅰ,Ⅱ vs Ⅲ, Ⅳ: 78.6% vs 56.3%, P = 0.035) and lymphatic metastasis (without vs with: 85.7% vs 53.1%, P = 0.034). The expression of Axin protein was not markedly correlated with the age and gender of patients, tumor size, biological features and serosa invasion (P 〉 0.05). CONCLUSION: The expression of Axin protein is down-regulated in gastric carcinoma, which correlates with the genesis and metastasis of the disease.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第8期763-766,共4页 World Chinese Journal of Digestology
关键词 Axin蛋白 胃癌 肿瘤发生 肿瘤转移 Axin protein Gastric carcinoma Carcinogenesis Metastasis
  • 相关文献

参考文献22

  • 1Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL 3rd, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997; 90: 181-192
  • 2Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 2000; 11: 273-282
  • 3He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512
  • 4Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426
  • 5Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes Chromosomes Cancer 2000; 28: 443-453
  • 6Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24: 245-250
  • 7Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001; 61: 8247-8255
  • 8Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sorensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsch T. Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res 2001; 61: 7039-7043
  • 9Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H, Kuwano H. Reduced expression of Axin correlates with tumour progression of oesophageal squamous cell carcinoma. Br J Cancer 2003; 88: 1734-1739
  • 10Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, Kikuchi A. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol 1998; 18: 2867-2875

同被引文献71

  • 1姚广裕,杨名添,戎铁华,何萍.MT1-MMP在乳腺癌组织中的表达及临床意义[J].癌症,2004,23(z1):1482-1486. 被引量:10
  • 2戴文斌.Wnt通路成员APC、β-catenin、c-myc及黏附分子E-cadherin与大肠癌的关系[J].中国肿瘤临床与康复,2007,14(1):73-75. 被引量:8
  • 3董承伟,丁怡,曾勇.Axin基因与肿瘤相关性的研究进展[J].国际病理科学与临床杂志,2007,27(1):36-39. 被引量:3
  • 4Karim R, Tse G, Putti T, Scolyer R, Lee S. The significance of the Wnt pathway in the pathology of human cancers[J]. Pathology, 2004,36 : 120-128.
  • 5Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y. Identification of membrane type matrix metalloproteinase-1 as a target of the β-catenin/Tcf4 complex in human colorectal cancers[J]. Oncogene, 2002,21 : 5861-5867.
  • 6Ishizaki Y, Ikeda S, Fujimori M, Shimizu Y, Kurihara T, Itamoto T,et al. Immunohistochemical analysis and mutational analysesof beta-catenin, Axin family and APC genes in hepatocellular carcinomas[J]. Int J Oncol, 2004,24 : 1077-1083.
  • 7Kudo J, Nishiwaki T, Haruki N, Ishiguro H, Shibata Y, Terashita Y, et al. Aberrant nueIear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer[J]. World J Surg Oncol, 2007,5 : 21-30.
  • 8Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M. Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma[J]. Int J Cancer, 2004,110 : 201-207.
  • 9Nakajima M, Fukuchi M, Miyazaki T, Masuda N, Kato H, Kuwano H. Reduced expression of Axin correlates with tumor progression of esophageal squamous cell carcinoma[J]. Br J Cancer, 2003,88:1734-1739.
  • 10Yamamoto H, Adachi Y, Itoh F, Iku S, Matsuno K, Kusano M, et al. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma [J]. Cancer Res, 1999,59:3313-3316.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部